e8vk
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 16, 2011
MedQuist Holdings Inc.
(Exact name of registrant as specified in charter)
         
Delaware   001-35069   98-0676666
(State of Incorporation or
Organization)
  Commission File Number)   (IRS Employer Identification
No.)
9009 Carothers Parkway,
Franklin, Tennessee 37067
(Address of principal executive offices) (Zip Code)
(866) 295-4600
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 


 

Item 2.02. Results of Operations and Financial Condition.
     On May 16, 2011, MedQuist Holdings Inc. (the “Company”) issued a press release announcing its results of operations for the first quarter ended March 31, 2011. A copy of the press release is furnished herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
     (d) Exhibits. The following exhibit is being furnished herewith to this Current Report on Form 8-K.
     
Exhibit No   Description
 
   
99.1
  Press Release dated May 16, 2011

 


 

Signatures
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  MedQuist Holdings Inc.
 
 
Date: May 16, 2011  By:   /s/ Mark R. Sullivan    
    Mark R. Sullivan   
    General Counsel & Chief Compliance Officer   

 


 

         
INDEX TO EXHIBITS
     
Exhibit Number   Description of Exhibit
 
   
99.1
  Press Release dated May 16, 2011